The Dubliner was booked to face Michael Chandler last summer but the bout was cancelled after he broke his toe.

A live webcast of the fireside chat will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and ...

Investors in Zai Lab Limited (NASDAQ:ZLAB) had a good week, as its shares rose 2.5% to close at US$34.64 following the release of its annual results. Revenue hit US$399m in line with forecasts ...

BofA downgraded Zai Lab (ZLAB) to Neutral from Buy with a price target of $36.10, up from $29. The firm cites the growth slowdown of the company’s core products and its belief that Zai’s near ...

Profitability Target: Expected to achieve profitability in Q4 2025. Zai Lab Ltd (NASDAQ:ZLAB) reported a 50% year-over-year revenue growth for 2024, with a 66% increase in the fourth quarter alone.

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following ...

Shares of ZLAB opened at $35.39 on Tuesday. Zai Lab has a one year low of $13.48 and a one year high of $36.60. The stock has a 50-day moving average price of $28.10 and a 200 day moving average ...

Goldman Sachs analysts added Zai Lab (ZLAB) to the firm’s APAC Conviction List as part of its monthly update. The firm says the company is transitioning from a licensing-in based China-only ...

Revenue: US$399.0m (up 50% from FY 2023). Net loss: US$257.1m (loss narrowed by 23% from FY 2023). US$2.60 loss per share (improved from US$3.46 loss in FY 2023). Revenue exceeded analyst ...